EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective effects of berberine-loaded chitosan/solid lipid nanoparticles in streptozotocin-induced gestational diabetes mellitus rats

Yu Liu, Shaik Althaf Hussain, Hua Yue

Experimental Biology and Medicine · 2025

DOI: 10.3389/ebm.2025.10749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Biology and Medicine, 2025. Verfasst von Yu Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, XD Group Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Berberine, Chitosan, Diabetes, Gestational, Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Berberine, known as an antioxidant agent, can improve glycemic indices in animal models of diabetes; however, it is clinically limited by poor bioavailability. Nanoparticles show the desirable capacity as delivery platforms for improving the bioavailability of medicinal agents. Here, we aimed to enhance the bioavailability and therapeutic impacts of berberine in streptozotocin (STZ)-induced gestational diabetes mellitus (GDM) rats by its encapsulation into the chitosan-coated solid lipid nanoparticles (SLNs) formulation. Berberine-loaded chitosan/SLN nanoparticles were formulated by the solvent-injection approach followed by a homogenization operation. The particle size, surface charge, and polydispersity index, as well as encapsulation efficiency percent (EE%), in vitro stability and berberine release, and in vivo pharmacokinetics were studied. Glycemic indices, such as fasting glucose and insulin, oral glucose tolerance, insulin tolerance, and homeostasis model of insulin resistance (HOMA-IR) scores, as well as the activity level of liver antioxidant and pro-oxidant enzymes, were evaluated in STZ-induced GDM rats. The particle size of berberine-loaded chitosan/SLN formulation was detected in the nano-range with high stability and high EE% as well as a sustained-release profile. Berberine nanoparticle treatment could provide a significantly higher oral bioavailability of berberine in experimental rats. Berberine nanoparticles remarkably reversed the altered glycemic indices, body weight, and pro-oxidant/antioxidant balance in STZ-induced GDM rats, with significantly higher effects than free berberine. In conclusion, chitosan-coated SLN nanoparticles firmly enhanced the therapeutic impacts of berberine on STZ-induced GDM, suggesting chitosan-coated SLN nanoparticles as an efficient oral delivery system for enhancing the bioavailability of berberine and, thus, improving its pharmacological impacts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineChitosanDiabetes, GestationalNanoparticlesDiabetes Mellitus, ExperimentalAnimalsFemalePregnancyRatsBlood GlucoseParticle SizeStreptozocinRats, Sprague-DawleyLipidsBiological AvailabilityAntioxidants

Stichwörter der Autor:innen

berberinechitosangestational diabetes mellitusratsolid lipid nanoparticle

Substanzen

BerberineChitosanBlood GlucoseStreptozocinLipidsAntioxidants

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, XD Group Hospital, Xi'an, China.
  • Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.

Zitieren

APA

Liu, Y., Hussain, S. A., & Yue, H. (2025). Protective effects of berberine-loaded chitosan/solid lipid nanoparticles in streptozotocin-induced gestational diabetes mellitus rats. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2025.10749

Vancouver

Liu Y, Hussain SA, Yue H. Protective effects of berberine-loaded chitosan/solid lipid nanoparticles in streptozotocin-induced gestational diabetes mellitus rats. Experimental Biology and Medicine. 2025. doi:10.3389/ebm.2025.10749

BibTeX
@article{Liu2025,
  author = {Liu, Yu and Hussain, Shaik Althaf and Yue, Hua},
  title = {Protective effects of berberine-loaded chitosan/solid lipid nanoparticles in streptozotocin-induced gestational diabetes mellitus rats},
  journal = {Experimental Biology and Medicine},
  year = {2025},
  doi = {10.3389/ebm.2025.10749}
}
Kostenlos starten →